A Retrospective Matched Case–Control Study on Medical Costs of Refractory Migraine in Taiwan

• DOI: 10.1111/head.12039
• Publication Date: 2013-02-13T18:09:57Z
• Authors: Chao‐Hsiun Tang; Yong‐Chen Chen; Kwong Ng; Shuu‐Jiun Wang
• Keywords: Medical costs; Medical record

Background Migraine is associated with a significant economic burden in W estern countries. However, there limited information regarding the impact of cost migraine A sia. Objectives To quantify and compare direct medical costs refractory ( RM ) other migraine, using health insurance claims data T aiwan. Methods retrospective matched case–control study was conducted utilizing from aiwan N ational H ealth I nsurance R esearch D atabase. cases were defined as patients at least 1 neurological outpatient visit primary or secondary nternational C lassification iseases, inth evision, linical M odification code 346.11 (common intractable so stated), diagnosed by certified neurologists centers during 2007‐2008. The first control group non‐migraineurs 4:1 ratio age, gender, urbanization level residence, income. second types (346.00, 346.10, 346.20, 346.80, 346.90) hospital setting. Medical utilization within 365 days after index date assessed 2‐part model. exchange rate for US $1 NT $32.50. Results Patients had significantly higher total compared $57,932 [ $1783] vs $26,817 $825]; P < .001) migraineurs $54,678 $1682] $38,397 $1181]; .001). mean drug those also than $19,752 $608] $8660 $266]; $17,623 $542] $10,088 $310]; In addition, we reviewed charts all an department diagnostic (n = 98) our aipei V eterans G eneral ospital, center aiwan) 2007. Of these patients, 88 (90%) fulfilled Silberstein– L ipton criteria chronic ie, >15 headache per month presence history migraine. Conclusions Refractory either diagnoses.